Literature DB >> 8526932

The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site.

K Löster1, K Zeilinger, D Schuppan, W Reutter.   

Abstract

A remarkable property of the integral glycoprotein dipeptidyl peptidase IV (DPP IV, CD 26) is its affinity to proteins of the extracellular matrix (ECM). By in vitro binding assays we have shown that DPP IV binds to collagens; preferentially to the collagens I and III, which are both characterized by the formation of large triplehelical domains. No binding of DPP IV to laminin or fibronectin could be observed. Within collagen I, the alpha 1(I) chain was found to be the most prominent binding ligand of DPP IV. A monoclonal anti DPP IV antibody (13.4) specifically inhibited the interaction of DPP IV with collagen I. Peptide mapping and N-terminal sequencing revealed that the corresponding epitope of mAb 13.4 is located in the cysteine-rich domain of DPP IV. We therefore conclude that the putative collagen binding site of DPP IV is different from the region of the catalytic site containing the exopeptidase activity, which is located at the C-terminal portion of the molecule.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526932     DOI: 10.1006/bbrc.1995.2782

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

Review 1.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

2.  A typhus group-specific protease defies reductive evolution in rickettsiae.

Authors:  Nicole C Ammerman; Joseph J Gillespie; Andrew F Neuwald; Bruno W Sobral; Abdu F Azad
Journal:  J Bacteriol       Date:  2009-10-09       Impact factor: 3.490

3.  Stromal expression of CD34, α-smooth muscle actin and CD26/DPPIV in squamous cell carcinoma of the skin: a comparative immunohistochemical study.

Authors:  Ayper Kacar; Ata Türker Arikok; Tuba Dilay Kokenek Unal; Evrim Onder; Sema Hucumenoglu; Murat Alper
Journal:  Pathol Oncol Res       Date:  2011-06-15       Impact factor: 3.201

Review 4.  DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.

Authors:  Jixin Zhong; Andrei Maiseyeu; Stephen N Davis; Sanjay Rajagopalan
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

5.  Molecular mechanism for connective tissue destruction by dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis.

Authors:  Yumi Kumagai; Hisao Yagishita; Ayako Yajima; Tatsuya Okamoto; Kiyoshi Konishi
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions.

Authors:  J S Duke-Cohan; J Gu; D F McLaughlin; Y Xu; G J Freeman; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 7.  The expression of proline-specific enzymes in the human lung.

Authors:  Gwendolyn Vliegen; Tom K Raju; Dirk Adriaensen; Anne-Marie Lambeir; Ingrid De Meester
Journal:  Ann Transl Med       Date:  2017-03

8.  The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices.

Authors:  Giulio Ghersi; Qiang Zhao; Monica Salamone; Yunyun Yeh; Stanley Zucker; Wen-Tien Chen
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 9.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

10.  Lymphatic-specific expression of dipeptidyl peptidase IV and its dual role in lymphatic endothelial function.

Authors:  Jay W Shin; Giorgia Jurisic; Michael Detmar
Journal:  Exp Cell Res       Date:  2008-08-03       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.